Ranbaxy starts generic Lipitor shipments from India
MUMBAI (Reuters) - Ranbaxy Laboratories Ltd has started exports of a copycat version of blockbuster cholesterol drug Lipitor from a new facility in India that has been approved by the U.S. Food And Drug Administration. The company, majority owned by Japan's Daiichi Sankyo, has been selling the generic version in the United States since last December 1 from its facility in America but exports to the United States from its plants in India were banned in 2009 over disputes related to compliance issues. Ranbaxy, India's biggest drugmaker by sales, said on Monday the U.S. ... read more..
source:http://yhoo.it/H8ExcH
